OKYO Pharma's short interest declined by 20.4% in May, reaching 63,300 shares on May 15th.

OKYO Pharma (NASDAQ:OKYO) experienced a 20.4% decline in short interest in May, totaling 63,300 shares on May 15th, down from 79,500 shares on April 30th. The current short-interest ratio is 0.9 days, and 0.3% of the company's shares are sold short. HC Wainwright raised their target price from $6.00 to $7.00 and gave the stock a "buy" rating on March 22nd.

June 01, 2024
3 Articles

Further Reading